ePrints

In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.

Lookup NU author(s): Dr Katherine Sturgess, Dr Rachel Dickinson, Professor Andrew GenneryORCiD, Professor Andrew Cant, Professor Graham Jackson, Professor Sophie Hambleton, Professor Mary Slatter, Dr Venetia BigleyORCiD, Professor Matthew CollinORCiD

Downloads

• Accepted version [.pdf]

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by American Society of Hematology, 2018.

For re-use rights please refer to the publisher's terms and conditions.

Abstract

Key points • Fludarabine-based reduced intensity transplantation with T depletion is safe and effective • Severe infection or respiratory compromise are indications for transplantation, even in the absence of myeloid neoplasia

Publication metadata

Author(s): Tholouli E, Sturgess K, Dickinson RE, Gennery A, Cant AJ, Jackson G, Lordan J, Hambleton S, Slatter MA, Bigley V, Collin M

Publication type: Article

Publication status: Published

Journal: Blood

Year: 2018

Volume: 131

Issue: 12

Pages: 1383-1387

Online publication date: 02/01/2018

Acceptance date: 18/12/2017

Date deposited: 26/01/2018

ISSN (print): 0006-4971

ISSN (electronic): 1528-0020

Publisher: American Society of Hematology

URL: https://doi.org/10.1182/blood-2017-10-811489

DOI: 10.1182/blood-2017-10-811489

PubMed id: 29295841

Altmetrics

Share